The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter randomized phase II study of trastuzumab biosimilar (CT-P6) and chemotherapy (SOX or CapeOX) in HER2-positive advanced/recurrent gastric cancer (KSCC: TROX study).
 
Teppei Yamada
No Relationships to Disclose
 
Yuichiro Nakashima
No Relationships to Disclose
 
Tomomi Kashiwada
No Relationships to Disclose
 
Hideto Sonoda
No Relationships to Disclose
 
Masashi Hattori
No Relationships to Disclose
 
Hirofumi Kawanaka
No Relationships to Disclose
 
Yasushi Tsuji
No Relationships to Disclose
 
Akitaka Makiyama
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Tetsuya Kusumoto
No Relationships to Disclose
 
Ikuo Takahashi
No Relationships to Disclose
 
Yudai Shinohara
No Relationships to Disclose
 
Masahiro Goto
Honoraria - MSD K.K.
Research Funding - Chugai Pharma; Nippon Kayaku; Taiho Pharmaceutical
 
Yoshiaki Shindo
No Relationships to Disclose
 
Kentaro Sawada
No Relationships to Disclose
 
Tatsunori Sakai
No Relationships to Disclose
 
Mototsugu Shimokawa
No Relationships to Disclose
 
Hiroshi Saeki
No Relationships to Disclose
 
Eiji Oki
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Guardant Health